Reference
Ross E, et al. The Clinical Role and Cost-effectiveness of Long-acting Antiretroviral Formulations. IDWeek 2013 : abstr. 78, 2 Oct 2013. Available from: URL: https://idsa.confex.com/idsa/2013/webprogram/Paper41458.html
Rights and permissions
About this article
Cite this article
Long-acting ART could improve survival, but may be too costly. PharmacoEcon Outcomes News 689, 8 (2013). https://doi.org/10.1007/s40274-013-0798-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-013-0798-3